Document is current
Any future updates will be listed below
-
Authors
Ding, Yali
Zhang, Bo
Payne, Jonathon L.
Song, Chunhua
Ge, Zheng
Gowda, Chandrika
Iyer, Soumya
Dhanyamraju, Pavan K.
Dorsam, Glenn
Reeves, Mark E.
Desai, Dhimant
Huang, Suming
Payne, Kimberly J. https://orcid.org/0000-0002-7025-5821
Yue, Feng
Dovat, Sinisa
-
Funding
Funding for this research was provided by:
Pharmaceutical Research and Manufacturers of America Foundation
U.S. Department of Health & Human Services | National Institutes of Health (F30CA221109, R01CA213912, R01DK110108, R01CA204044, R01CA209829, R35GM124820, R01HG009906, R01CA209829, R01CA213912)
Four Diamonds Fund of the Pennsylvania State University College of Medicine
St. Baldrick's Foundation
Bear Necessities
Hyundai Motor Group | Hyundai Motor America | Hyundai Hope On Wheels
Alex's Lemonade Stand Foundation for Childhood Cancer
Bear Necessities Pediatric Cancer Foundation John Wawrynovic Leukemia Research Scholar Endowment Four Diamonds Fund of the Pennsylvania State University College of Medicine
- License Information
-
More Information
Article History
Received: 18 November 2018
Revised: 15 February 2019
Accepted: 19 March 2019
First Online: 9 May 2019
Compliance with ethical standards
:
: Kimberly J. Payne is CEO and owns stock and Sinisa Dovat is on the board of directors of Elf Zone, Inc., a startup company developing therapies for B-cell acute lymphoblastic leukemia. Elf Zone, Inc. did not provide support for this work. The remaining authors declare that they have no conflict of interest.
